BioNeutra Global Corporation
BGA.V
TSX
| 09/30/2023 | 06/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -19.53% | 6.12% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -19.53% | 6.12% | |||
| Cost of Revenue | -40.51% | 6.86% | |||
| Gross Profit | 129.26% | 1.15% | |||
| SG&A Expenses | -13.61% | 26.13% | |||
| Depreciation & Amortization | -2.08% | 5.37% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -30.88% | 12.38% | |||
| Operating Income | 65.77% | -37.26% | |||
| Income Before Tax | -7.98% | -34.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -7.98% | -34.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.98% | -34.88% | |||
| EBIT | 65.77% | -37.26% | |||
| EBITDA | 90.52% | -59.90% | |||
| EPS Basic | -8.12% | -34.93% | |||
| Normalized Basic EPS | 53.66% | -33.70% | |||
| EPS Diluted | -0.45% | -50.68% | |||
| Normalized Diluted EPS | 53.66% | -33.70% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
